Shima Nabavi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shima Nabavi has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Abolghasem Allahyari
Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Adele Azarshab
Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Afshin Sarraf
Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication Alireza Bary
Department of Hematology Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication- Farnoosh Ebrahimzadeh
Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Hamid Reza Rahimi
Department of Medical Genetics and Molecular Medicine, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication
Latest Publications
- 7 May 2026
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 14 (1) , 34761
Association of serum calcium, phosphorus, and vitamin D Levels with clinical severity in patients with chronic obstructive pulmonary disease: A single-center study
Introduction: This study aimed to evaluate serum concentrations of calcium, phosphorus, and vitamin D in patients diagnosed with chronic obstructive pulmonary disease (COPD). Methods: This study was conducted at the Mashhad University of Medical Sciences, Iran, between 2021 and 2022, focused on assessing the neutrophil-to-lymphocyte ratio (NLR) in COPD patients. Data was collected from clinical files, laboratory results, and direct patient interviews, with an emphasis on demographic data, medical history, and a variety of laboratory and clinical parameters. COPD severity was assessed using clinical criteria and spirometry. Results: The study included 49 COPD patients, with a mean age of 62.3±8.70 years, 59% of whom were male. Common comorbidities included hypertension (43%) and diabetes (12%). Serum analysis indicated an average calcium level of 9.50 mg/dL and vitamin D3 level of 26 ng/ml. Most patients were prescribed SEROFLO (82%) and TIOVA (92%). Severity of COPD was categorized as 49% in mMRC Grade 2, 43% in AECOPD Category 0, and 67% in GOLD Grade 2. A significant variation in vitamin D3 levels was observed across different GOLD Spirometry Classifications (P=0.02). However, there was no significant correlation observed between calcium and phosphorus levels and COPD severity indicators. Conclusion: The study revealed a significant variation in vitamin D3 levels among different GOLD Spirometry Classifications in COPD patients, suggesting that vitamin D3 may play a role in the severity of COPD. However no significant association was found for calcium and phosphorus levels with COPD severity, their role should not be disregarded and warrants further investigation.
- 7 May 2026
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 14 (1) , 34761
Association of serum calcium, phosphorus, and vitamin D Levels with clinical severity in patients with chronic obstructive pulmonary disease: A single-center study
Introduction: This study aimed to evaluate serum concentrations of calcium, phosphorus, and vitamin D in patients diagnosed with chronic obstructive pulmonary disease (COPD). Methods: This study was conducted at the Mashhad University of Medical Sciences, Iran, between 2021 and 2022, focused on assessing the neutrophil-to-lymphocyte ratio (NLR) in COPD patients. Data was collected from clinical files, laboratory results, and direct patient interviews, with an emphasis on demographic data, medical history, and a variety of laboratory and clinical parameters. COPD severity was assessed using clinical criteria and spirometry. Results: The study included 49 COPD patients, with a mean age of 62.3±8.70 years, 59% of whom were male. Common comorbidities included hypertension (43%) and diabetes (12%). Serum analysis indicated an average calcium level of 9.50 mg/dL and vitamin D3 level of 26 ng/ml. Most patients were prescribed SEROFLO (82%) and TIOVA (92%). Severity of COPD was categorized as 49% in mMRC Grade 2, 43% in AECOPD Category 0, and 67% in GOLD Grade 2. A significant variation in vitamin D3 levels was observed across different GOLD Spirometry Classifications (P=0.02). However, there was no significant correlation observed between calcium and phosphorus levels and COPD severity indicators. Conclusion: The study revealed a significant variation in vitamin D3 levels among different GOLD Spirometry Classifications in COPD patients, suggesting that vitamin D3 may play a role in the severity of COPD. However no significant association was found for calcium and phosphorus levels with COPD severity, their role should not be disregarded and warrants further investigation.
- Open Access
- 1 October 2023
- Published by Farname, Inc. in Journal of Advances in Medical and Biomedical Research
- Vol. 31 (148) , 432-440
Effect of Oral Curcumin on Rheumatoid Arthritis Patients: A Double-Blind Randomized Clinical Trial
Background and Objective: Incomprehensive studies have examined the therapeutic and side effects of curcumin on the treatment of debilitating diseases, such as Rheumatoid Arthritis (RA). This study aimed to explore the anti-inflammatory effects of curcumin on RA. Materials and Methods: This double-blind clinical trial was carried out on 64 RA patients with ...
- 1 October 2023
- Published by Farname, Inc. in Journal of Advances in Medical and Biomedical Research
- Vol. 31 (148) , 432-440
Open AccessEffect of Oral Curcumin on Rheumatoid Arthritis Patients: A Double-Blind Randomized Clinical Trial
Background and Objective: Incomprehensive studies have examined the therapeutic and side effects of curcumin on the treatment of debilitating diseases, such as Rheumatoid Arthritis (RA). This study aimed to explore the anti-inflammatory effects of curcumin on RA. Materials and Methods: This double-blind clinical trial was carried out on 64 RA patients with ...
- Open Access
- 18 October 2020
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
- Vol. 7 (2) , e19
Investigation of hematological parameters related to the severity of COVID-19 disease in Mashhad, Iran
Introduction:Human coronavirus disease 2019 (COVID-19) is an emerging respiratory disease that has become pandemic worldwide. The patients have a range of mild to severe symptoms, such as pneumonia, acute respiratory distress syndrome, arrhythmia, shock, and other organs involvement. Clinical and hematological evidence can serve as a prognostic factor to detect severe cases of COVID-19. Objectives: The present study aimed to evaluate hematological parameters related to the severity of the disease in COVID-19 patients in Mashhad, Eastern Iran. Patients and Methods: All the individuals with positive real-time reverse transcription-polymerase chain reaction test results and the patients with clinical symptoms whose computed tomography scan results were matched with the diagnosis of viral pneumonia were included in the study. The hematological examinations and complete blood count of the patients were performed by the healthcare personnel through collecting blood samples at the time of admission and discharge from the hospital. Results: In total, 189 COVID-19 patients were included in the study, 47.6% and 58.73% of whom were over 60 years old and male, respectively. Investigation of the hematological parameters revealed that the number of white blood cells, mean value of corpuscular volume, number of platelets, and lymph count had significantly increased at the time of discharge (PPP=0.021). Conclusion: It can be concluded that hematological parameters and inflammatory biomarkers in COVID-19 patients could potentially act as the independent factors and affect the prognosis of the disease.
- 18 October 2020
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
- Vol. 7 (2) , e19
Open AccessInvestigation of hematological parameters related to the severity of COVID-19 disease in Mashhad, Iran
Introduction:Human coronavirus disease 2019 (COVID-19) is an emerging respiratory disease that has become pandemic worldwide. The patients have a range of mild to severe symptoms, such as pneumonia, acute respiratory distress syndrome, arrhythmia, shock, and other organs involvement. Clinical and hematological evidence can serve as a prognostic factor to detect severe cases of COVID-19. Objectives: The present study aimed to evaluate hematological parameters related to the severity of the disease in COVID-19 patients in Mashhad, Eastern Iran. Patients and Methods: All the individuals with positive real-time reverse transcription-polymerase chain reaction test results and the patients with clinical symptoms whose computed tomography scan results were matched with the diagnosis of viral pneumonia were included in the study. The hematological examinations and complete blood count of the patients were performed by the healthcare personnel through collecting blood samples at the time of admission and discharge from the hospital. Results: In total, 189 COVID-19 patients were included in the study, 47.6% and 58.73% of whom were over 60 years old and male, respectively. Investigation of the hematological parameters revealed that the number of white blood cells, mean value of corpuscular volume, number of platelets, and lymph count had significantly increased at the time of discharge (PPP=0.021). Conclusion: It can be concluded that hematological parameters and inflammatory biomarkers in COVID-19 patients could potentially act as the independent factors and affect the prognosis of the disease.